NAA10 gene expression is associated with mesenchymal transition, dedifferentiation, and progression of clear cell renal cell carcinoma.

We aimed to investigate the expression and prognostic role of NAA10 in clear cell renal cell carcinoma (ccRCC).

We performed a gene expression and survival analysis based on the human cancer genome atlas database of ccRCC patients (TCGA-KIRC).

The patients in the TCGA-KIRC (n = 537) were divided into two subgroups: NAA10-low and NAA10-high expression groups. NAA10-high ccRCC exhibited higher T stages (p = 0.002), a higher frequency of distant metastasis (p = 0.018), more advanced AJCC stages (p < 0.001), a lower overall survival time (p = 0.036), and a lower survival rate (p < 0.001). NAA10-high ccRCC was associated with increased activity of non-specific oncogenic pathways, including oxidative phosphorylation (p < 0.001) and cell cycle progression [G2 to M phase transition (p = 0.045) and E2F targets (p < 0.001)]. Additionally, the NAA10-high tumors showed reduced apoptosis via TRIAL pathways (p < 0.001) and increased levels of activity that promoted epithelial-mesenchymal transition (p = 0.026) or undifferentiation (p = 0.01). In ccRCC, NAA10 expression was found to be a negative prognostic factor in both non-metastatic (p < 0.001) and metastatic tumors (p = 0.032).

In ccRCC, NAA10 expression was shown to be a negative prognostic factor related to tumor progression rather than tumor initiation, and high NAA10 expression promoted epithelial-mesenchymal transition and undifferentiation.

Pathology, research and practice. 2024 Feb 07 [Epub ahead of print]

Nguyen Xuong Duong, Thao Nguyen, Minh-Khang Le, Norifumi Sawada, Satoru Kira, Tetsuo Kondo, Takeshi Inukai, Takahiko Mitsui

Department of Urology, University of Yamanashi Graduate School of Medical Sciences, Chuo-city 409-3898, Japan; Department of Urology, Cho Ray Hospital, Ho Chi Minh city, Vietnam. Electronic address: ., Department of Pediatrics, University of Yamanashi Graduate School of Medical Sciences, Chuo-city 409-3898, Japan. Electronic address: ., Department of Human Pathology, University of Yamanashi Graduate School of Medical Sciences, Chuo-city 409-3898, Japan. Electronic address: ., Department of Urology, University of Yamanashi Graduate School of Medical Sciences, Chuo-city 409-3898, Japan. Electronic address: ., Department of Urology, University of Yamanashi Graduate School of Medical Sciences, Chuo-city 409-3898, Japan. Electronic address: ., Department of Human Pathology, University of Yamanashi Graduate School of Medical Sciences, Chuo-city 409-3898, Japan. Electronic address: ., Department of Pediatrics, University of Yamanashi Graduate School of Medical Sciences, Chuo-city 409-3898, Japan. Electronic address: ., Department of Urology, University of Yamanashi Graduate School of Medical Sciences, Chuo-city 409-3898, Japan. Electronic address: .